Mala Shanmugam (M Shanmugam)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Top Venues

Nature communications

Science advances

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Vilas A Gupta, Shannon M Matulis, Benjamin G Barwick, R Devin Bog, Conrad W Shebelut, Mala Shanmugam, Paola Neri, Nizar J Bahlis, Madhav V Dhodapkar, Leonard T Heffner, Craig C Hofmeister, Nisha S Joseph, Sagar Lonial, Jonathan L Kaufman, David L Jaye, Ajay K Nooka, Lawrence H Boise
Venetoclax ex vivo functional profiling predicts improved progression-free survival. Blood cancer journal 12 (8) (2022)
Aditi Sharma, Remya Nair, Abhinav Achreja, Anjali Mittal, Pulkit Gupta, Kamakshi Balakrishnan, Claudia L Edgar, Olamide Animasahun, Bhakti Dwivedi, Benjamin G Barwick, Vilas A Gupta, Shannon M Matulis, Manoj K Bhasin, Sagar Lonial, Ajay K Nooka, Arun P Wiita, Lawrence H Boise, Deepak Nagrath, Mala Shanmugam
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma. Science advances 8 (39) (2022)
R Commander, C Wei, Aditi Sharma, J K Mouw, L J Burton, Emily R Summerbell, D Mahboubi, R J Peterson, J Konen, Wei Zhou, Y Du, Haian Fu, Mala Shanmugam, A I Marcus
Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion. Nature communications 11 (1) (2020)
Richa Bajpai, Aditi Sharma, Abhinav Achreja, Claudia L Edgar, Changyong Wei, Arusha A Siddiqa, Vikas A Gupta, Shannon M Matulis, Samuel K McBrayer, Anjali Mittal, Manali Rupji, Benjamin G Barwick, Sagar Lonial, Ajay K Nooka, Lawrence H Boise, Deepak Nagrath, Mala Shanmugam
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nature communications 11 (1) (2020)
Aditi Sharma, Lawrence H Boise, Mala Shanmugam
Cancer Metabolism and the Evasion of Apoptotic Cell Death. Cancers 11 (8) (2019)